WebNov 30, 2024 · In addition to the approval of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, a derivative product from its production, called Pathogen Reduced Plasma, Cryoprecipitate Reduced, has also been... WebNov 30, 2024 · CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) today announced that the US Food and Drug Administration (FDA) has granted approval …
Homepage - Cerus Corporate Site
WebCerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen … Annual Meeting - Homepage - Cerus Corporate Site Products - Homepage - Cerus Corporate Site Leadership - Homepage - Cerus Corporate Site Press Releases - Homepage - Cerus Corporate Site About Cerus - Homepage - Cerus Corporate Site Learn - Homepage - Cerus Corporate Site Careers - Homepage - Cerus Corporate Site Mission and Values - Homepage - Cerus Corporate Site Blood Matters - Homepage - Cerus Corporate Site WebCerus.com The corporate website includes broad information about Cerus, resources for investors, and career opportunities. INTERCEPT-USA.com For residents of the United … tim wise white like me summary
Cerus Update: Tailwinds Now Include FDA Approval Of ... - SeekingAlpha
WebPMA: BP140143. Device Generic Name: Pathogen Reduction System for Platelets. Tradename: INTERCEPT® Blood System for Platelets. Manufacturer: Cerus … WebApr 13, 2024 · The fund owned 243,450 shares of the biotechnology company’s stock after selling 4,665 shares during the period. Exchange Traded Concepts LLC owned about 0.14% of Cerus worth $889,000 as of its ... WebDec 16, 2014 · Cerus Corporation is a biomedical products company focused in the field of blood safety. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. tim wise white privilege